565 related articles for article (PubMed ID: 16753278)
1. An engineered vascular endothelial growth factor-activating transcription factor induces therapeutic angiogenesis in ApoE knockout mice with hindlimb ischemia.
Xie D; Li Y; Reed EA; Odronic SI; Kontos CD; Annex BH
J Vasc Surg; 2006 Jul; 44(1):166-75. PubMed ID: 16753278
[TBL] [Abstract][Full Text] [Related]
2. Engineered zinc finger-activating vascular endothelial growth factor transcription factor plasmid DNA induces therapeutic angiogenesis in rabbits with hindlimb ischemia.
Dai Q; Huang J; Klitzman B; Dong C; Goldschmidt-Clermont PJ; March KL; Rokovich J; Johnstone B; Rebar EJ; Spratt SK; Case CC; Kontos CD; Annex BH
Circulation; 2004 Oct; 110(16):2467-75. PubMed ID: 15477407
[TBL] [Abstract][Full Text] [Related]
3. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
[TBL] [Abstract][Full Text] [Related]
4. An engineered VEGF-activating zinc finger protein transcription factor improves blood flow and limb salvage in advanced-age mice.
Yu J; Lei L; Liang Y; Hinh L; Hickey RP; Huang Y; Liu D; Yeh JL; Rebar E; Case C; Spratt K; Sessa WC; Giordano FJ
FASEB J; 2006 Mar; 20(3):479-81. PubMed ID: 16423874
[TBL] [Abstract][Full Text] [Related]
5. A vascular endothelial growth factor activating transcription factor increases the endothelial progenitor cells population and induces therapeutic angiogenesis in a type 1 diabetic mouse with hindlimb ischemia.
Diao Y; Lian L; Guo L; Chen H; Chen Y; Song X; Li Y
Chin Med J (Engl); 2014; 127(20):3623-9. PubMed ID: 25316240
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic angiogenesis for ischemic syndromes.
Weisz A; Koren B; Fischer L; Lewis BS; Flugelman MY
Isr Med Assoc J; 2000 Jul; 2 Suppl():52-7. PubMed ID: 10909418
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.
Taniyama Y; Morishita R; Aoki M; Nakagami H; Yamamoto K; Yamazaki K; Matsumoto K; Nakamura T; Kaneda Y; Ogihara T
Gene Ther; 2001 Feb; 8(3):181-9. PubMed ID: 11313789
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor stimulates angiogenesis without improving collateral blood flow following hindlimb ischemia in rabbits.
Hershey JC; Baskin EP; Corcoran HA; Bett A; Dougherty NM; Gilberto DB; Mao X; Thomas KA; Cook JJ
Heart Vessels; 2003 Jul; 18(3):142-9. PubMed ID: 12955430
[TBL] [Abstract][Full Text] [Related]
9. An engineered transcription factor which activates VEGF-A enhances recovery after spinal cord injury.
Liu Y; Figley S; Spratt SK; Lee G; Ando D; Surosky R; Fehlings MG
Neurobiol Dis; 2010 Feb; 37(2):384-93. PubMed ID: 19879362
[TBL] [Abstract][Full Text] [Related]
10. [Experimental study on treatment of acute limb ischemia with vascular endothelial growth factor-121 gene transfer].
Zheng ZH; Xu L; Fan XH
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2004 Mar; 18(2):142-5. PubMed ID: 15065417
[TBL] [Abstract][Full Text] [Related]
11. Induction of angiogenesis by cationic lipid-mediated VEGF165 gene transfer in the rabbit ischemic hindlimb model.
Gowdak LH; Poliakova L; Li Z; Grove R; Lakatta EG; Talan M
J Vasc Surg; 2000 Aug; 32(2):343-52. PubMed ID: 10917995
[TBL] [Abstract][Full Text] [Related]
12. Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.
Jacobi J; Tam BY; Wu G; Hoffman J; Cooke JP; Kuo CJ
Circulation; 2004 Oct; 110(16):2424-9. PubMed ID: 15477417
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle.
Gounis MJ; Spiga MG; Graham RM; Wilson A; Haliko S; Lieber BB; Wakhloo AK; Webster KA
Gene Ther; 2005 May; 12(9):762-71. PubMed ID: 15772688
[TBL] [Abstract][Full Text] [Related]
14. VEGF-D is the strongest angiogenic and lymphangiogenic effector among VEGFs delivered into skeletal muscle via adenoviruses.
Rissanen TT; Markkanen JE; Gruchala M; Heikura T; Puranen A; Kettunen MI; Kholová I; Kauppinen RA; Achen MG; Stacker SA; Alitalo K; Ylä-Herttuala S
Circ Res; 2003 May; 92(10):1098-106. PubMed ID: 12714562
[TBL] [Abstract][Full Text] [Related]
15. Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization.
Yu JX; Huang XF; Lv WM; Ye CS; Peng XZ; Zhang H; Xiao LB; Wang SM
J Vasc Surg; 2009 Sep; 50(3):608-16. PubMed ID: 19595531
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of stromal cell-derived factor-1alpha enhances ischemic vasculogenesis and angiogenesis via vascular endothelial growth factor/endothelial nitric oxide synthase-related pathway: next-generation chemokine therapy for therapeutic neovascularization.
Hiasa K; Ishibashi M; Ohtani K; Inoue S; Zhao Q; Kitamoto S; Sata M; Ichiki T; Takeshita A; Egashira K
Circulation; 2004 May; 109(20):2454-61. PubMed ID: 15148275
[TBL] [Abstract][Full Text] [Related]
17. Polydeoxyribonucleotide (PDRN) restores blood flow in an experimental model of peripheral artery occlusive disease.
Bitto A; Polito F; Altavilla D; Minutoli L; Migliorato A; Squadrito F
J Vasc Surg; 2008 Nov; 48(5):1292-300. PubMed ID: 18971038
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular gene transfer of soluble tumor necrosis factor-alpha receptor 1 activates vascular endothelial growth factor receptor and accelerates angiogenesis in a rat model of hindlimb ischemia.
Sugano M; Tsuchida K; Makino N
Circulation; 2004 Feb; 109(6):797-802. PubMed ID: 14970118
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis induced by endothelial nitric oxide synthase gene through vascular endothelial growth factor expression in a rat hindlimb ischemia model.
Namba T; Koike H; Murakami K; Aoki M; Makino H; Hashiya N; Ogihara T; Kaneda Y; Kohno M; Morishita R
Circulation; 2003 Nov; 108(18):2250-7. PubMed ID: 14568906
[TBL] [Abstract][Full Text] [Related]
20. A phosphodiesterase-5 inhibitor vardenafil enhances angiogenesis through a protein kinase G-dependent hypoxia-inducible factor-1/vascular endothelial growth factor pathway.
Sahara M; Sata M; Morita T; Nakajima T; Hirata Y; Nagai R
Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1315-24. PubMed ID: 20413734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]